Clinical Trials Directory

Trials / Completed

CompletedNCT01549340

Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

Evaluation of Patient Initiation and Persistence With Advised Allergen Immunotherapy

Status
Completed
Phase
Study type
Observational
Enrollment
8,790 (actual)
Sponsor
ALK-Abelló A/S · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the proportion of participants that initiate allergen immunotherapy (AIT) upon the recommendation of their physician and the proportion of participants that persist with their AIT throughout the recommended course.

Conditions

Timeline

Start date
2011-11-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2012-03-09
Last updated
2017-03-03
Results posted
2014-03-06

Source: ClinicalTrials.gov record NCT01549340. Inclusion in this directory is not an endorsement.